First-line single-agent regorafenib in frail patients with metastatic colorectal cancer: a pilot phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)

Peer Review reports

Original Submission
4 Dec 2018	Submitted	Original manuscript
4 Mar 2019	Reviewed	Reviewer Report - Eric Chen
12 Mar 2019	Reviewed	Reviewer Report - Mei-Chin Hsieh
16 Apr 2019	Author responded	Author comments - Alfredo Carrato
Resubmission - Version 2
16 Apr 2019	Submitted	Manuscript version 2
29 Apr 2019	Reviewed	Reviewer Report - Mei-Chin Hsieh
17 May 2019	Reviewed	Reviewer Report - Eric Chen
21 May 2019	Author responded	Author comments - Alfredo Carrato
Resubmission - Version 3
21 May 2019	Submitted	Manuscript version 3
Publishing
27 May 2019	Editorially accepted
3 Jun 2019	Article published	10.1186/s12885-019-5753-7

Back to article page